Leica Novocastra CD71 Mode D'emploi page 56

Protitelesa družbe Leica Biosystems Newcastle Ltd so namenjena uporabi, kot je navedeno, na zamrznjenih ali v parafin vstavljenih
rezinah z določenimi zahtevami za fiksiranje. Lahko pride do nepričakovanega izražanja antigena, zlasti pri neoplazmah. Pri klinični
razlagi obarvane rezine tkiva morate upoštevati morfološko analizo in oceno ustreznih kontrol.
Splošna literatura
1. National Committee for Clinical Laboratory Standards (NCCLS). Protection of laboratory workers from infectious diseases
transmitted by blood and tissue; proposed guideline. Villanova, P.A. 1991; 7(9). Order code M29-P.
2. Battifora H. Diagnostic uses of antibodies to keratins: a review and immunohistochemical comparison of seven monoclonal and
three polyclonal antibodies. Progress in Surgical Pathology. 6:1–15. eds. Fenoglio-Preiser C, Wolff CM, Rilke F. Field & Wood, Inc.,
Philadelphia.
3. Nadji M, Morales AR. Immunoperoxidase, part I: the techniques and pitfalls. Laboratory Medicine. 1983; 14:767.
4. Omata M, Liew CT, Ashcavai M, Peters RL. Nonimmunologic binding of horseradish peroxidase to hepatitis B surface antigen: a
possible source of error in immunohistochemistry. American Journal of Clinical Pathology. 1980; 73:626.
5. Dong HY, Wilkes S and Yang H. CD71 is selectively and ubiquitously expressed at high levels in erythroid precursors of all maturation
stages: a comparative immunochemical study with glycophorin A and hemoglobin A. American Journal of Surgical Pathology. 2011;
35(5):723-732.
6. Magro G, Cataldo I, Amico P, et al. Aberrant expression of TfR1/CD71 in thyroid carcinomas identifies a novel potential diagnostic
marker and therapeutic target. Thyroid. 2011; 21(3):267-277.
7. Menier C, Rabreau M, Challier JC, et al. Erythroblasts secrete the nonclassical HLA-G molecule from primitive to definitive
hematopoiesis. Blood. 2004; 104(10):3153-3160.
Dodatki in spremembe k prejšnji izdaji
Posodobitev na obliko pričakovanih rezultatov, dodatek prevedenega besedila.
Datum izdaje
01 november 2018
CD71-309
Page 55